Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Gocke

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Annals of the New York Academy of Sciences|May 20, 2000
Cellular- versus extracellular-based assays. Comparing utility in DNA and RNA molecular marker assessmentM S Kopreski, C D Gocke
Annals of the New York Academy of Sciences|November 16, 2001
Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serumM S Kopreski, F A Benko, C D Gocke
Histochemistry and Cell Biology|December 29, 2000
The human homologue of the Aspergillus nuclear migration gene nudC is preferentially expressed in dividing cells and ciliated epitheliaC D Gocke, S A Osmani, B A Miller
Human Genetics|April 1, 1998
Transmission of mitochondrial DNA heteroplasmy in normal pedigreesC D Gocke, F A Benko, P K Rogan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Detection of tumor messenger RNA in the serum of patients with malignant melanomaM S Kopreski, F A Benko, L W Kwak, et al.
Human Pathology|January 1, 1997
KRAS oncogene mutations suggest a common histogenetic origin for pleomorphic giant cell tumor of the pancreas, osteoclastoma of the pancreas, and pancreatic duct adenocarcinomaC D Gocke, D J Dabbs, F A Benko, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Enrichment methods for mutation detectionC D Gocke, F A Benko, M S Kopreski, et al.
Obstetrics and Gynecology|May 8, 1998
Placental pathology in maternal and neonatal myeloproliferative disordersS E Lentz, C C Coulson, C D Gocke, et al.
Annals of the New York Academy of Sciences|May 20, 2000
p53 and APC mutations are detectable in the plasma and serum of patients with colorectal cancer (CRC) or adenomasC D Gocke, F A Benko, M S Kopreski, et al.
Leukemia|December 22, 2015
The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cellsE Chang, S Ganguly, T Rajkhowa, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Annals of the New York Academy of Sciences|May 20, 2000
Cellular- versus extracellular-based assays. Comparing utility in DNA and RNA molecular marker assessmentM S Kopreski, C D Gocke
Annals of the New York Academy of Sciences|November 16, 2001
Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serumM S Kopreski, F A Benko, C D Gocke
Histochemistry and Cell Biology|December 29, 2000
The human homologue of the Aspergillus nuclear migration gene nudC is preferentially expressed in dividing cells and ciliated epitheliaC D Gocke, S A Osmani, B A Miller
Human Genetics|April 1, 1998
Transmission of mitochondrial DNA heteroplasmy in normal pedigreesC D Gocke, F A Benko, P K Rogan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Detection of tumor messenger RNA in the serum of patients with malignant melanomaM S Kopreski, F A Benko, L W Kwak, et al.
Human Pathology|January 1, 1997
KRAS oncogene mutations suggest a common histogenetic origin for pleomorphic giant cell tumor of the pancreas, osteoclastoma of the pancreas, and pancreatic duct adenocarcinomaC D Gocke, D J Dabbs, F A Benko, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Enrichment methods for mutation detectionC D Gocke, F A Benko, M S Kopreski, et al.
Obstetrics and Gynecology|May 8, 1998
Placental pathology in maternal and neonatal myeloproliferative disordersS E Lentz, C C Coulson, C D Gocke, et al.
Annals of the New York Academy of Sciences|May 20, 2000
p53 and APC mutations are detectable in the plasma and serum of patients with colorectal cancer (CRC) or adenomasC D Gocke, F A Benko, M S Kopreski, et al.
Leukemia|December 22, 2015
The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cellsE Chang, S Ganguly, T Rajkhowa, et al.
Pageof 3